Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats

被引:25
|
作者
Ikeda, Y
Nakamura, T [1 ]
Takano, H
Kimura, H
Obata, JE
Takeda, S
Hata, A
Shido, K
Mochizuki, S
Yoshida, Y
机构
[1] Yamanashi Med Univ, Div Blood Transfus, Yamanashi 4093898, Japan
[2] Yamanashi Med Univ, Dept Internal Med, Yamanashi 4093898, Japan
[3] Yamanashi Med Univ, Dept Pathol, Yamanashi 4093898, Japan
[4] Hokkaido Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 060, Japan
[5] Jikei Univ, Sch Med, Aoto Hosp, Dept Med, Tokyo, Japan
来源
关键词
D O I
10.1067/mlc.2000.105617
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Angiotensin-converting enzyme inhibitors (ACEIs) cause regression of hypertensive left ventricular hypertrophy (LVH) by reducing angiotensin II, increasing bradykinin, or both. The mechanisms of these cardioprotective effects remain controversial. The aims of this study were to determine whether the cardioprotective effects of ACEIs are mediated by reducing angiotensin II and whether ACEIs ameliorate the morphologic, physiologic, and biochemical changes in the hearts of stroke-prone spontaneously hypertensive rats (SHRSPs). Male SHRSPs were treated with hydralazine, captopril, or candesartan, an angiotensin II type 1 receptor(AT1R) antagonist, from age 12 to 24 weeks. We measured systolic blood pressure (SBP), left ventricular weight (LVW), left ventricular (LV) myocyte cross-sectional area (myocyte size), LV interstitial collagen volume fraction (ICVF), perivascular collagen area/luminal area ratio (PVCA/LA), the medial area to luminal area ratio (MA/LA), the relative amount of V3 myosin heavy chain (MHCV3), and coronary reserve maximum (coronary flow max/ventricular weight (CFmax/VW)). These parameters were compared with those of untreated SHRSPs and Wistar-Kyoto mts (WKYs). SHRSPs exhibited decreased coronary reserve and LVH with an increase in myocyte size, PVCA/LA, MA/LA, and MHCV3 at 12 weeks of age. In addition to these changes, 24-week-old SHRSPs showed an increase in ICVF. The LVW coronary reserve, myocyte size, PVCA/LA, ICVF, and MHCV3 of SHRSPs treated with captopril or candesartan all approached control values. In contrast, hydralazine decreased only ICVF. These results suggest that ACEIs regress LVH and normalize coronary reserve by modulating the effects of angiotensin II via AT1R on the induction of cardiomyocyte hypertrophy, perivascular fibrosis, and medial thickening of intramyocardial coronary arteries in SHRSPs. We concluded that these effects, in addition to the reduction of SEP, are important in causing the regression of LVH.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 50 条
  • [31] VASOPRESSIN IN THE PLASMA OF STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    RASCHER, W
    WEIDMANN, E
    GROSS, F
    CLINICAL SCIENCE, 1981, 61 (03) : 295 - 298
  • [32] HEART-BOUND ADIPONECTIN, NOT SERUM ADIPONECTIN, CORRELATES WITH CARDIAC HYPERTROPHY IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    Inoue, Takao
    Takemori, Kumiko
    Muzuguchi, Nobuyuki
    Kimura, Masatomo
    Chikugo, Takaaki
    Hagiyama, Man
    Yoneshige, Azusa
    Mori, Tatsufumi
    Kometani, Takashi
    Itoh, Tatsuki
    Satou, Takao
    Ito, Akihiko
    JOURNAL OF HYPERTENSION, 2016, 34 : E288 - E288
  • [33] Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats
    Li, PG
    Xu, JW
    Ikeda, K
    Kobayakawa, A
    Kayano, Y
    Mitani, T
    Ikami, T
    Yamori, Y
    HYPERTENSION RESEARCH, 2005, 28 (04) : 369 - 377
  • [34] Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats
    Kim-Mitsuyama, S
    Yamamoto, E
    Tanaka, T
    Zhan, Y
    Izumi, Y
    Izumiya, Y
    Ioroi, T
    Wanibuchi, H
    Iwao, H
    STROKE, 2005, 36 (05) : 1077 - 1082
  • [35] Caffeic Acid Inhibits Vascular Smooth Muscle Cell Proliferation Induced by Angiotensin II in Stroke-Prone Spontaneously Hypertensive Rats
    Peng-Gao Li
    Jin-Wen Xu
    Katsumi Ikeda
    Akira Kobayakawa
    Yasuyo Kayano
    Takahiko Mitani
    Takao Ikami
    Yukio Yamori
    Hypertension Research, 2005, 28 : 369 - 377
  • [36] Angiotensin(1-7) increases survival of stroke-prone spontaneously hypertensive rats
    Regenhardt, Robert William
    Ritucci-Chinni, Phillip
    Desland, Fiona
    Mecca, Adam Peter
    Sumners, Colin
    FASEB JOURNAL, 2011, 25
  • [37] Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats
    Morgan, Hannah L.
    Butler, Elaine
    Ritchie, Shona
    Herse, Florian
    Dechend, Ralf
    Beattie, Elisabeth
    McBride, Martin W.
    Graham, Delyth
    HYPERTENSION, 2018, 72 (01) : 208 - 218
  • [38] Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats
    Savoia, C
    Tabet, F
    Yao, GY
    Schiffrin, EL
    Touyz, RM
    JOURNAL OF HYPERTENSION, 2005, 23 (05) : 1037 - 1045
  • [39] HISTOLOGICAL AND HISTOMETRICAL STUDY OF MYOCARDIAL FIBROSIS IN SPONTANEOUSLY HYPERTENSIVE RATS OF THE STROKE-PRONE STRAIN
    SAWAMURA, I
    HAZAMA, F
    KINOSHITA, M
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1990, 54 (10): : 1274 - 1282
  • [40] Effects of cyclosporine A on angiotensin II-induced cardiomyocyte hypertrophy in neonatal rats
    Han Zhaomin
    Yang Yunhai
    Zhang Kailun
    Xiang Jizhou
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2005, 25 (5): : 558 - 560